Menu Back toS49-Forefront-of-Patient-Technology-in-Clinical-Trials

16th DIA Japan Annual Meeting 2019

Delivering Rational Medicine for All People in the Globe

[S49] Forefront of Patient Technology in Clinical Trials

Session Chair(s)

Tempei  Miyaji, MSc

Tempei Miyaji, MSc

  • Project Assistant Professor, Department of Clinical Trial Data Management
  • The University of Tokyo, Japan
Patient technology (PT) has the potential to make a significant impact on the patient-focused clinical trials. In this session, status and outcomes in Japan and global on cutting edge PT for promoting clinical trial information sharing, patient recruitment and patient-friendly clinical trials will be shared.


David  Leventhal, MBA

TransCelerate Patient Experience Overview

David Leventhal, MBA

  • Senior Director, Clinical Trial Experience
  • Pfizer Inc, United States
Matthew  Moyer, MBA, MS, PMP

Tools for Enabling and Accelerating Patient-Facing Digital Technologies

Matthew Moyer, MBA, MS, PMP

  • Director
  • Merck & Co., Inc., United States
Ryo  Masada

eConsent Implementation in Japan

Ryo Masada

  • Pharma Clinical Study Management, Trial Monitoring, Global Drug Development
  • Novartis Pharma K.K., Japan
Jiao  Song, PhD

Marching Toward Patient-Centricity: How Technologies Are Transforming Clinical Research

Jiao Song, PhD

  • Associate Director, Janssen Clinical Innovation
  • Janssen R&D, LLC., United States